Evidence map›Paper›PMID 26810212›Full record

ArticleBMC complementary and alternative medicine2016

Chemical composition, antioxidant and anticholinesterase potentials of essential oil of Rumex hastatus D. Don collected from the North West of Pakistan.

Sajjad Ahmad, Farhat Ullah, Abdul Sadiq, Muhammad Ayaz, Muhammad Imran, Imdad Ali, Anwar Zeb, Farman Ullah, Muhammad Raza Shah

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
16.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 100 citations in OpenAlex.

  1. Transcriptional regulation ofGM crops & food · 2025
    Article
  2. Article
  3. Assessment of the Inhibition of AChE and BChE byCurrent Alzheimer research · 2025
    Article
  4. Metabolites · 2023
    Article
  5. Wild Mushrooms: A Hidden Treasure of Novel Bioactive Compounds.International journal of analytical chemistry · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. In-vitro and in-vivo pharmacological screening of Iris Albican.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2022
    Article
  13. Review
  14. In Vivo Antiplasmodial Potential of the Leaf, Mesocarp, and Epicarp of theEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Sajjad AhmadDepartment of Pharmacy, University of Malakand, Chakdara 18000, Dir (L), KPK, Pakistan. sajad4u2000@yahoo.com.
Farhat UllahDepartment of Pharmacy, University of Malakand, Chakdara 18000, Dir (L), KPK, Pakistan. farhataziz80@hotmail.com.
Abdul SadiqDepartment of Pharmacy, University of Malakand, Chakdara 18000, Dir (L), KPK, Pakistan. sadiquom@yahoo.com.
Muhammad AyazDepartment of Pharmacy, University of Malakand, Chakdara 18000, Dir (L), KPK, Pakistan. ayazuop@gmail.com.
Muhammad ImranDepartment of Pharmacy, University of Malakand, Chakdara 18000, Dir (L), KPK, Pakistan. imranbjr.khan@gmail.com.
Imdad AliInternational Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry University of Karachi, Karachi, Pakistan. imdadchem26@gmail.com.
Anwar ZebDepartment of Pharmacy, University of Malakand, Chakdara 18000, Dir (L), KPK, Pakistan. zeb.takor@yahoo.com.
Farman UllahDepartment of Pharmacy, Kohat University of Science &Technology, Kohat, Pakistan. pharmankhan@yahoo.com.
Muhammad Raza ShahInternational Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry University of Karachi, Karachi, Pakistan. raza.shah@iccs.edu.
University of Malakand · PKInternational Center for Chemical and Biological Sciences · PKKohat University of Science and Technology · PKUniversity of Karachi · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEthnomedicinally Rumex hastatus D. Don has been used since long for various ailments especially in neurological disorders. The reported data and the importance of Rumex genus demonstrate the vital medicinal value of R. hastatus.

methodsIn the current investigational study, isolation of essential oil and its antioxidant and anticholinesterase assays were performed. The essential oil of R. hastatus was analyzed by GC-MS for the first time. The essential oil was evaluated for anticholinesterase and antioxidant assays. The anticholinesterase assay was conducted at various concentrations (62.5 to 1000 μg/ml) against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Similarly, the antioxidant potential was determined using DPPH and ABTS free radicals.

resultsThe GC-MS analysis of essential oil showed 123 components. The result recorded for the anticholinesterase assays demonstrated a marked potential against AChE and BChE with IC50 values of 32.54 and 97.38 μg/ml respectively which were comparable with the positive control i.e., galanthamine (AChE, IC50 = 4.73 μg/ml and BChE, IC50 = 11.09 μg/ml). The antioxidant assays against DPPH and ABTS free radicals also exhibited significant scavenging potential with IC50 values of 3.71 and 6.29 μg/ml respectively, while for ascorbic acid the IC50 value was <0.1 μg/ml against both free radicals.

conclusionsBased on the current investigational studies, it may be concluded that R. hastatus is an effective source of essential oil's components having anticholinesterase and antioxidant potentials, which after subjecting to drug development may lead to novel drug candidates against neurodegenerative disorders.

Indexed as

AntioxidantsCholinesterase InhibitorsGas Chromatography-Mass SpectrometryOils, VolatilePakistanRumexAntioxidantsCholinesterase InhibitorsOils, Volatile

Identifiers

PMID26810212
PMCPMC4727414
OpenAlexW2259737148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.